Objectives: Overview of the Safety and Efficacy of Zeposia
This Product Theater is sponsored by Bristol Myers Squibb and is not affiliated with AGA.
Eosinophilic Esophagitis - Nielsen Q. Fernandez-Becker, MD, PhD
Dysphagia: Diagnosis & Management in 2021 - John O. Clarke, MD, AGAF
GERD & Barrett's Esophagus - Monica Nandwani, DNP, RN, FNP-BC
Nausea and Vomiting - Shreya Raja, MD
Chronic Constipation - Moriane Joseph, MSN, MPH, ARNP
Handling The Hemorrhage: Managing GI Bleeding - Patrick I. Okolo, III, MD, MPH, FASGE, FHTC, FACG
Abdominal Pain and Interpretation of Radiology Images - Lawrence R. Kosinski, MD, MBA, AGAF
Dr. Siegel discusses CDPATH, which uses a blood test to evaluate an adult patient’s potential risk within 3 years of developing bowel strictures, internal penetrating disease, or non-perianal surgery (bowel resection or stricturoplasty). Used with physician’s assessment, CDPATH can help facilitate shared decision-making (U.S. availability; no cost to eligible patients).
This Product Theater is sponsored by Takeda and is not affiliated with AGA.
This virtual symposium, sponsored by AbbVie, is a case-based presentation highlighting clinical considerations in the differential diagnosis of common GI conditions associated with chronic diarrhea. We will share insights regarding the symptoms, diagnostic challenges, and management of exocrine pancreatic insufficiency (EPI) and irritable bowel syndrome with diarrhea (IBS-D).
Click here to download a supplemental resource about the differential diagnosis of chronic diarrhea: http://www.access-medical.com/EPIandIBSHandout.pdf
This Product Theater is sponsored by AbbVie and is not affiliated with AGA.